W. Brandon Ingersoll

Co-Founder & Partner

MedEquity Capital

Joined: 1999

Office Phone:

(781) 237-6910


  Pro - Try 1 Week Free
 

    and access,

  •     75K PE/M&A Contacts
  •     +
  •     4.5K PE Firms
  •     3.6K M&A Advisors
  •     191K Transactions
  •     196K Companies

  •     Market Services
  •     Build Lists
  •     Research Sectors
  •     Uncover Opportunities

Bio

Brandon is one of the founding partners of MedEquity Capital. While at MedEquity he has sourced, managed and run a number of the firm’s investments in the specialty pharmacy, OTC medications and outsourcing sectors. He currently serves as the Operating Chairman of PharmaLogic. In that role, he has sourced and closed over 33 pharmacy acquisitions on their behalf. PharmaLogic has grown to become the largest independent radiopharmacy in North America during his tenure as Chairman. His other board and operating roles include Operating Chairman for Belmar Pharma Solutions and CEO of LiceGuard, LLC. Prior to MedEquity, he worked in the healthcare group at Bain & Company. Brandon also was previously the Product Marketing Manager of Health Payment Review, a leading HCIT software provider to payors backed by Greylock Capital, just after they were acquired by McKesson. He has a degree in economics from Brigham Young University (Magna Cum Laude), an MBA from the Harvard Business School and is a member of the Phi Beta Kappa honor society. When not at work he enjoys mountain biking, skiing, kayaking and playing guitar.

Education

Brigham Young University , Utah,
1 of 44

Harvard Business School , Massachusetts,
1 of 660